Key result
High-density lipoprotein cholesterol is inversely associated with cardiovascular disease risk, but definitive evidence of an independent atheroprotective role in humans remains lacking.
Answers are grounded in this paper and cite their sources.
There is unequivocal evidence of an inverse association between plasma high-density lipoprotein (HDL) cholesterol concentrations and the risk of cardiovascular disease, a finding that has led to the hypothesis that HDL protects from atherosclerosis. This review details the experimental evidence for this "HDL hypothesis". In vitro studies suggest that HDL has a wide range of anti-atherogenic properties but validation of these functions in humans is absent to date. A significant number of animal studies and clinical trials support an atheroprotective role for HDL; however, most of these findings were obtained in the context of marked changes in other plasma lipids. Finally, genetic studies in humans have not provided convincing evidence that HDL genes modulate cardiovascular risk. Thus, despite a wealth of information on this intriguing lipoprotein, future research remains essential to prove the HDL hypothesis correct.
No takes yet. Share an insight, caveat, or question.
Vergeer et al. (2010) conducted a review in Atherosclerosis and cardiovascular disease. High-density lipoprotein (HDL) cholesterol was evaluated. High-density lipoprotein cholesterol is inversely associated with cardiovascular disease risk, but definitive evidence of an independent atheroprotective role in humans remains lacking.
Synapse has enriched 10 related papers. Consider them for comparative context: